Yiannakou, Yan
National Health Service · County Durham and Darlington NHS Foundation Trust
6 papers on CoChatORCID 0000-0001-8437-2925
Most cited papers
- Verified
British Society of Gastroenterology guidelines on the management of irritable bowel syndrome
Vasant, D. H., Paine, P. A., Black, C. J., Houghton, L. A., Everitt, H. A., Corsetti, M., Agrawal, A., Aziz, I., Farmer, A. D., Eugenicos, M. P., et al. (2021) · Gut
Gastrointestinal motility and disordersInfant Health and Development
Cited by 592
- Verified
Epidemiological, Clinical, and Psychological Characteristics of Individuals with Self-reported Irritable Bowel Syndrome Based on the Rome IV vs Rome III Criteria
Black, C. J., Yiannakou, Y., Houghton, L. A., & Ford, A. C. (2020) · Clinical Gastroenterology and Hepatology
Gastrointestinal motility and disordersPsychosomatic Disorders and Their Treatments
Cited by 123
- Verified
A randomized, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy, safety, and tolerability of prucalopride in men with chronic constipation
Yiannakou, Y., Piessevaux, H., Bouchoucha, M., Schiefke, I., Filip, R., Gabalec, L., Dina, I., Stephenson, D., Kerstens, R., Etherson, K., et al. (2015) · American Journal of Gastroenterology
Gastrointestinal motility and disordersPelvic floor disorders treatments
Cited by 104
- Verified
Anxiety‐related factors associated with symptom severity in irritable bowel syndrome
Black, C. J., Yiannakou, Y., Houghton, L. A., Shuweihdi, F., West, R., Guthrie, E., & Ford, A. C. (2020) · Neurogastroenterology & Motility
Gastrointestinal motility and disordersPsychosomatic Disorders and Their Treatments
Cited by 48
- Verified
Randomised, double-blind, placebo controlled multi-centre study to assess the efficacy, tolerability and safety of Enterosgel® in the treatment of irritable bowel syndrome with diarrhoea (IBS-D) in adults
Kemppinen, A., Howell, C., Allgar, V., Dodd, M., Gregson, J., Knowles, C., McLaughlin, J., Pandya, P., Whorwell, P., Markaryan, E., et al. (2020) · Trials
Gastrointestinal motility and disordersInfant Health and Development
Cited by 14
- Verified
UK clinical experience up to 52 weeks with linaclotide for irritable bowel syndrome with constipation
Yiannakou, Y., Agrawal, A., Allen, P. B., Arebi, N., Brown, S. R., Eugenicos, M. P., Farmer, A. D., McLain-Smith, S., McLaughlin, J., Sanders, D. S., et al. (2018) · Therapeutic Advances in Gastroenterology
Gastrointestinal motility and disordersInflammatory Bowel Disease
Cited by 12
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free